CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-01 | Monahan Joseph Chief Scientific Officer | Exercise or conversion | +50,000 | 281,995 | ||
| 2025-03-01 | Monahan Joseph Chief Scientific Officer | Exercise or conversion | +10,925 | 292,920 | ||
| 2025-03-01 | Monahan Joseph Chief Scientific Officer | Shares withheld for taxes | −27,258 | $1.99 | $54K | 265,662 |
| 2025-03-01 | Monahan Joseph Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −50,000 | 0 | ||
| 2025-03-01 | Monahan Joseph Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −10,925 | 10,925 | ||
| 2025-02-03 | Monahan Joseph Chief Scientific Officer | Grant or award · Restricted Stock Units | +83,900 | 83,900 | ||
| 2025-02-03 | Monahan Joseph Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +293,500 | 293,500 | ||
| 2025-02-01 | Monahan Joseph Chief Scientific Officer | Exercise or conversion | +7,500 | 228,562 | ||
| 2025-02-01 | Monahan Joseph Chief Scientific Officer | Exercise or conversion | +14,750 | 243,312 | ||
| 2025-02-01 | Monahan Joseph Chief Scientific Officer | Shares withheld for taxes | −11,317 | $2.48 | $28K | 231,995 |
| 2025-02-01 | Monahan Joseph Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −7,500 | 15,000 | ||
| 2025-02-01 | Monahan Joseph Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −14,750 | 44,250 | ||
| 2025-01-02 | Monahan Joseph Chief Scientific Officer | Exercise or conversion | +17,380 | 229,976 | ||
| 2025-01-02 | Monahan Joseph Chief Scientific Officer | Shares withheld for taxes | −8,914 | 221,062 | ||
| 2025-01-02 | Monahan Joseph Chief Scientific Officer | Grant or award · Restricted Stock Units | +52,667 | 52,667 | ||
| 2025-01-02 | Monahan Joseph Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −17,380 | 35,287 | ||
| 2024-12-31 | Monahan Joseph Chief Scientific Officer | Exercise or conversion | +73,750 | 245,533 | ||
| 2024-12-31 | Monahan Joseph Chief Scientific Officer | Shares withheld for taxes | −32,937 | 212,596 | ||
| 2024-12-31 | Monahan Joseph Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −73,750 | 73,750 | ||
| 2024-12-10 | Monahan Joseph Chief Scientific Officer | Gift | −15,000 | 171,783 |
Page 1 of 4 · 73 trades